Prostate Adenocarcinoma Clinical Trials

257 clinical trials for Prostate Adenocarcinoma across international registries, including 58 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Enzalutamide Implants (Enolen) in Patients With Prostate Cancer — RECRUITING · PHASE1
• Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes — RECRUITING · PHASE2
• Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound — RECRUITING · NA
• Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer — RECRUITING · PHASE2
• A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer — RECRUITING · PHASE2
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy — RECRUITING · PHASE2
• Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) — RECRUITING · NA
• Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial — RECRUITING · PHASE2
• Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor — RECRUITING · PHASE2
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma — RECRUITING · NA
• Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study — RECRUITING · PHASE2
• INSPIRE: INnovative SABR for Prostate Cancer All IREland — RECRUITING · PHASE2
• rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance — RECRUITING · PHASE1
• An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial — RECRUITING · PHASE1
• Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer — RECRUITING · PHASE3
• A Study of Lower Dose Radiation Therapy for People With Prostate Cancer — RECRUITING · PHASE2
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging — RECRUITING · PHASE3
• PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer — RECRUITING · PHASE2
• Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers — RECRUITING · NA
• The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction — RECRUITING · NA
• Two-fraction HDR Monotherapy for Localized Prostate Cancer — RECRUITING · NA
• Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial — RECRUITING · PHASE2
• Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy — RECRUITING · PHASE2
• Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer — RECRUITING · NA
• High-Risk prostatE Cancer radiatiOn Versus surgERy — RECRUITING
• Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance — RECRUITING · PHASE2
• Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial — RECRUITING · PHASE2
• Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer — RECRUITING · NA
• MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy — RECRUITING · NA
• PSMA PET Response Guided SabR in High Risk Pca — RECRUITING · PHASE1
• Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy — RECRUITING · PHASE2
• Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response — RECRUITING · NA
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial — RECRUITING · PHASE2
• Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) — RECRUITING · PHASE2
• Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer — RECRUITING · PHASE2
• A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer — RECRUITING · PHASE2
• Impact of Intraoperative ICG on Functional Outc in RARP — RECRUITING · PHASE1
• Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance — RECRUITING · PHASE2
• Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) — RECRUITING · PHASE2
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors — RECRUITING · PHASE1
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation — RECRUITING · PHASE2
• Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) — RECRUITING
• Personalized Optimization of Systematic Prostate Biopsy — RECRUITING · NA
• Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement — RECRUITING · NA
• Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer — RECRUITING · PHASE2
• Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy — RECRUITING · PHASE4
• ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials — RECRUITING
• Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer — RECRUITING · NA
• A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer — RECRUITING · PHASE1
• Customized TULSA-PRO Ablation Registry — RECRUITING

Refine this search